Brokerages Set Astera Labs, Inc. (NASDAQ:ALAB) Price Target at $325.25

Astera Labs, Inc. (NASDAQ:ALAB) has received an average rating of “Moderate Buy” from the twenty-three research firms that are currently covering the stock, Marketbeat.com reports. Eight research analysts have rated the stock with a hold recommendation, fourteen have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $333.00.

Several equities research analysts have commented on the company. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Citigroup reiterated a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Needham & Company LLC increased their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Finally, UBS Group restated a “neutral” rating and set a $425.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Analyst upgrade: Northland Securities raised Astera Labs to “Outperform,” supporting the bullish case for the stock. Northland Securities Upgrades Astera Labs to Outperform
• Positive Sentiment: AI connectivity demand: Coverage highlights record demand for Astera Labs’ connectivity products as AI data-center infrastructure expands. The company’s recent results reinforce that trend, with revenue up 104.5% year over year and earnings exceeding analyst expectations.
• Positive Sentiment: Strong growth profile: Astera Labs has posted accelerating quarterly revenue growth, while rising earnings estimates and demand for AI connectivity make it appear attractive relative to Broadcom in one comparison. ALAB vs. AVGO: Which AI Infrastructure Stock Is the Better Buy Now?
• Positive Sentiment: Platform expansion: Analysts argue Astera Labs is evolving beyond individual components into a broader AI-fabric platform, potentially increasing content per accelerator, customer stickiness and margins. Astera Labs: A Platform Getting Paid Like A Part
• Neutral Sentiment: Insider transactions: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares worth roughly $64 million combined. The filings state the sales were made to cover tax withholding on vested equity awards, making them less concerning than discretionary sales, though they may still weigh on sentiment. SEC insider transaction filing
• Negative Sentiment: High valuation and volatility: With a price-to-earnings ratio above 140 and shares trading below their 50-day moving average, investors may be taking profits or reducing exposure despite strong fundamentals. The stock’s elevated beta also increases sensitivity to market and AI-sector sentiment.

Astera Labs Stock Down 4.8%

Shares of ALAB stock opened at $289.02 on Thursday. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a market cap of $50.14 billion, a PE ratio of 143.08 and a beta of 3.84. The business has a 50-day simple moving average of $355.88 and a 200-day simple moving average of $243.65.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period last year, the company earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts anticipate that Astera Labs will post 2.7 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total value of $4,047,300.00. Following the completion of the transaction, the director owned 4,631 shares in the company, valued at $2,083,950. The trade was a 66.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders have sold 419,244 shares of company stock valued at $163,135,169. Insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Several institutional investors have recently bought and sold shares of the business. Royal Bank of Canada raised its stake in shares of Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the period. AQR Capital Management LLC grew its stake in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after acquiring an additional 7,756 shares during the period. Empowered Funds LLC grew its stake in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares during the period. First Trust Advisors LP increased its holdings in Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. increased its holdings in Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after acquiring an additional 1,977 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.